Anaemia in chronic obstructive pulmonary disease. Does it really matter?

International Journal of Clinical Practice

Volumn 67, Issue 6, 2013, Pages 558-565

  Portillo, K ^a   Martinez Rivera, C ^a,b   Ruiz Manzano, J ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; IRBESARTAN; OXYGEN; PLACEBO; THEOPHYLLINE;

ANEMIA; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DISEASE EXACERBATION; ERYTHROPOIESIS; HEALTH CARE COST; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; IRON DEPLETION; LUNG CANCER; MORBIDITY; MORTALITY; MUSCLE ATROPHY; OSTEOPOROSIS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIDE EFFECT;

ACUTE DISEASE; ANDROGENS; ANEMIA; CHRONIC DISEASE; ERYTHROPOIESIS; ERYTHROPOIETIN; EXERCISE TOLERANCE; GLOMERULAR FILTRATION RATE; HEALTH RESOURCES; HEMOGLOBINS; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RENAL INSUFFICIENCY, CHRONIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 84878048703     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12125     Document Type: Review

References (62)

1. Berry CE, Wise RA,. Mortality in COPD: causes, risk factors, and prevention. COPD 2010; 7: 375-8.
2. Barnes PJ, Celli BR,. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-85.
3. John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD,. Anemia and inflammation in COPD. Chest 2005; 127: 825-9. (Pubitemid 40775511)
4. Chambellan A, Chailleux E, Similowski T,. ANTADIR Observatory Group. Prognostic value of hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005; 128: 1201-8. (Pubitemid 41324396)
5. Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B,. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007; 29: 923-9. (Pubitemid 46711896)
6. John M, Lange A, Hoernig S, Witt C, Anker SD,. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol 2006; 111: 365-70. (Pubitemid 44205291)
7. Portillo K, Belda J, Antõn P, Casan P,. High frequency of anemia in COPD patients admitted in a tertiary hospital. Rev Clin Esp 2007; 207: 383-7. (Pubitemid 47414449)
8. Martinez-Rivera C, Portillo K, Muñoz-Ferrer A, et al. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD 2012; 9: 243-50.
9. Shorr AF, Doyle J, Stern L, Dolgitser M, Zilberberg MD,. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin 2008; 24: 1123-30, 923. (Pubitemid 351579170)
10. Nowiński A, Kamiński D, Korzybski D, Stokłosa A, Gõrecka D,. The impact of comorbidities on the length of hospital treatment in patients with chronic obstructive pulmonary disease. Pneumonol Alergol Pol 2011; 79: 388-96.
11. Halpern MT, Zilberberg MD, Schmier JK, Lau EC, Shorr AF,. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc 2006; 16: 17.
12. World Health Organization. Nutritional anemias: report of a WHO scientific group. WHO Technical Report Series 405. Geneva, World Health Organization, 1968; pp. 1-37.
13. Kollert F, Müller C, Tippelt A, et al. Anaemia in chronic respiratory failure. Int J Clin Pract 2011; 65: 479-86.
14. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC,. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004; 104: 2263-8. (Pubitemid 39331821)
15. Semenza GL,. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis. Blood 2009; 114: 2015-9.
16. Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA,. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol 2011; 58: 1241-51.
17. Okonko DO, Van Veldhuisen DJ, Poole-Wilson PA, Anker SD,. Anaemia of chronic disease in chronic heart failure: the emerging evidence. Eur Heart J 2005; 26: 2213-4. (Pubitemid 41541379)
18. Pavlisa G, Vrbanic V, Kusec V, Jaksic B,. Erythropoietin response after correction of severe hypoxaemia due to acute respiratory failure in chronic obstructive pulmonary disease patients. Clin Sci (Lond) 2004; 106: 43-51. (Pubitemid 38091338)
19. Vlahakos D, Kosmas E, Dimopoulou I, et al. Association between activation of the rennin angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease. Am J Med 1999; 106: 158-64. (Pubitemid 29115955)
20. Tsantes AE, Papadhimitriou SI, Tassiopoulos ST, et al. Red cell macrocytosis in hypoxemic patients with chronic obstructive pulmonary disease. Respir Med 2004; 98: 1117-23. (Pubitemid 39317942)
21. Tassiopoulos S, Kontos A, Konstantopoulos K, et al. Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease. Respir Med 2001; 95: 471-5. (Pubitemid 32622000)
22. Weiss G, Goodnough LT,. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-23.
23. Ferrucci L, Semba RD, Guralnik JM, et al. Proinflammatory state, hepcidin, and anemia in older persons. Blood 2010; 115: 3810-6.
24. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113: 1271-6. (Pubitemid 39069926)
25. Roy CN,. Anemia of inflammation. Hematology Am Soc Hematol Educ Program 2010; 2010: 276-80.
26. Boutou AK, Stanopoulos I, Pitsiou GG, et al. Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses. Respiration 2011; 82: 237-45.
27. Gan WQ, Man SF, Senthilselvan A, Sin DD,. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-80. (Pubitemid 38901515)
28. Tang YD, Katz SD,. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 2006; 113: 2454-61. (Pubitemid 43948053)
29. Agustí A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012; 7: e37483.
30. García-Rio F, Romero D, Lores V, et al. Dynamic hyperinflation, arterial blood oxygen, and airway oxidative stress in stable patients with COPD. Chest 2011; 140: 961-9.
31. MacNee W,. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 50-60. (Pubitemid 40562963)
32. Boutou AK, Pitsiou GG, Stanopoulos I, Kontakiotis T, Kyriazis G, Argyropoulou P,. Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study. QJM 2012; 105: 657-63.
33. Portillo K,. Anemia in COPD: should it be taken into consideration? Arch Bronconeumol 2007; 43: 392-8.
34. Soler-Cataluña JJ, Martínez-García MA, Catalán Serra P,. Impacto multidimensional de las exacerbaciones de la EPOC. Arch Bronconeumol 2010; 46 (Suppl. 11): 12-9.
35. Sala E, Balaguer C, Villena C, et al. Low erythropoietin plasma levels during exacerbations of COPD. Respiration 2010; 80: 190-7.
36. Markoulaki D, Kostikas K, Papatheodorou G, et al. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. Eur J Intern Med 2011; 22: 103-7.
37. Wedzicha JA, Cotes PM, Empey DW, Newland AC, Royston JP, Tam RC,. Serum immunoreactive erythropoietin in hypoxic lung diseasewith and without polycythaemia. Clin Sci 1985; 69: 413-22. (Pubitemid 15003813)
38. Fitzpatrick MF, Mackay T, Whyte KF, et al. Nocturnal desaturation and serum erythropoietin: a study in patients with chronic obstructive pulmonary disease and in normal subjects. Clin Sci 1993; 84: 319-24. (Pubitemid 23083114)
39. Laghi F, Adiguzel N, Tobin MJ,. Endocrinological derangements in COPD. Eur Respir J 2009; 34: 975-96.
40. Vlahakos DV, Marathias KP, Madias NE,. The role of the renin-angiotensin system in the regulation of erythropoiesis. Am J Kidney Dis 2010; 56: 558-65.
41. Mrug M, Stopka T, Julian BA, Prchal JF, Prchal JT,. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest 1997; 100: 2310-4. (Pubitemid 27500154)
42. Plata R, Cornejo A, Arratia C, et al. Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial. Lancet 2002; 359: 663-6. (Pubitemid 34203766)
43. Andreas S, Herrmann-Lingen C, Raupach T, et al. Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial. Eur Respir J 2006; 27: 972-9. (Pubitemid 44911111)
44. Pham I, Andrivet P, Sediame S, et al. Increased erythropoietin synthesis in patients with COLD or left heart failure is related to alterations in renal haemodynamics. Eur J Clin Invest 2001; 31: 103-9. (Pubitemid 32199901)
45. Zaritsky J, Young B, Wang HJ, et al. Hepcidin-a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 1051-6.
46. Incalzi RA, Corsonello A, Pedone C, et al. Extrapulmonary Consequences of COPD in the Elderly Study Investigators. Chronic renal failure: a neglected comorbidity of COPD. Chest 2010; 137: 831-7.
47. Casaburi R, Bhasin S, Cosentino L, et al. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 870-8. (Pubitemid 39346482)
48. Ferrucci L, Maggio M, Bandinelli S, et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 2006; 166: 1380-8. (Pubitemid 44036350)
49. Bakris GL, Sauter ER, Hussey JL, Fisher JW, Gaber AO, Winsett R,. Effects of theophylline in erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. N Engl J Med 1990; 323: 86-90. (Pubitemid 20221644)
50. Ilan Y, Dranitzki-Elhalel M, Rubinger D, Silver J, Popovtzer MM,. Erythrocytosis post renal transplantation: the response to theophylline treatment. Transplantation 1994; 57: 661-4. (Pubitemid 24106761)
51. Oren R, Beeri M, Hubert A, et al. Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease. Arch Intern Med 1997; 157: 1474-8. (Pubitemid 27300395)
52. Tsantes AE, Tassiopoulos ST, Papadhimitriou SI, et al. Theophylline treatment may adversely affect the anoxia-induced erythropoietic response without suppressing erythropoietin production. Eur J Clin Pharmacol 2003; 59: 379-83. (Pubitemid 37214942)
53. Similowski T, Agusti A, MacNee W, Schonhofer B,. The potential impact of anaemia of chronic disease in COPD. Eur Respir J 2006; 27: 390-6. (Pubitemid 43180920)
54. Chambellan A, Coulon S, Cavailles A, Hermine O, Similowski T,. COPD and erythropoiesis: interactions and consequences. Rev Mal Respir 2012; 29: 213-31.
55. Krishnan G, Grant BJ, Muti PC, et al. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med 2006; 6: 23.
56. Barba R, de Casasola GG, Marco J, et al. Anemia in chronic obstructive pulmonary disease: a readmission prognosis factor. Curr Med Res Opin 2012; 28: 617-22.
57. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-12. (Pubitemid 38269277)
58. Lima DF, Dela Coleta K, Tanni SE, Silveira LV, Godoy I, Godoy I,. Potentially modifiable predictors of mortality in patients treated with long-term oxygen therapy. Respir Med 2011; 105: 470-6.
59. Martínez FJ, Foster G, Curtis JL, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173: 1326-34. (Pubitemid 43900706)
60. Rasmussen L, Christensen S, Lenler-Petersen P, Johnsen SP,. Anemia and 90-day mortality in COPD patients requiring invasive mechanical ventilation. Clin Epidemiol 2011; 3: 1-5.
61. Schonhofer B, Wenzel M, Geibel M, Kohler D,. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med 1998; 26: 1824-8. (Pubitemid 28527693)
62. Schonhofer B, Bohrer H, Kohler D,. Blood transfusion facilitating difficult weaning from the ventilator. Anaesthesia 1998; 53: 181-4. (Pubitemid 28052367)